203 related articles for article (PubMed ID: 28750311)
1. Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues.
Nuti E; Bassani B; Camodeca C; Rosalia L; Cantelmo A; Gallo C; Baci D; Bruno A; Orlandini E; Nencetti S; Noonan DM; Albini A; Rossello A
Eur J Med Chem; 2017 Sep; 138():890-899. PubMed ID: 28750311
[TBL] [Abstract][Full Text] [Related]
2. Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation.
Gallo C; Dallaglio K; Bassani B; Rossi T; Rossello A; Noonan DM; D'Uva G; Bruno A; Albini A
Oncotarget; 2016 Sep; 7(37):59917-59931. PubMed ID: 27494895
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of xanthohumol analogues and discovery of potent thioredoxin reductase inhibitor as potential anticancer agent.
Zhang B; Duan D; Ge C; Yao J; Liu Y; Li X; Fang J
J Med Chem; 2015 Feb; 58(4):1795-805. PubMed ID: 25629304
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets.
Albini A; Dell'Eva R; Vené R; Ferrari N; Buhler DR; Noonan DM; Fassina G
FASEB J; 2006 Mar; 20(3):527-9. PubMed ID: 16403733
[TBL] [Abstract][Full Text] [Related]
5. Xanthohumol and related prenylated flavonoids inhibit inflammatory cytokine production in LPS-activated THP-1 monocytes: structure-activity relationships and in silico binding to myeloid differentiation protein-2 (MD-2).
Peluso MR; Miranda CL; Hobbs DJ; Proteau RR; Stevens JF
Planta Med; 2010 Oct; 76(14):1536-43. PubMed ID: 20309792
[TBL] [Abstract][Full Text] [Related]
6. Xanthohumol, a prenylated chalcone from beer hops, acts as an α-glucosidase inhibitor in vitro.
Liu M; Yin H; Liu G; Dong J; Qian Z; Miao J
J Agric Food Chem; 2014 Jun; 62(24):5548-54. PubMed ID: 24897556
[TBL] [Abstract][Full Text] [Related]
7. The inhibitory effects of xanthohumol, a prenylated chalcone derived from hops, on cell growth and tumorigenesis in human pancreatic cancer.
Jiang W; Zhao S; Xu L; Lu Y; Lu Z; Chen C; Ni J; Wan R; Yang L
Biomed Pharmacother; 2015 Jul; 73():40-7. PubMed ID: 26211581
[TBL] [Abstract][Full Text] [Related]
8. Novel anthraquinone based chalcone analogues containing an imine fragment: synthesis, cytotoxicity and anti-angiogenic activity.
Kolundžija B; Marković V; Stanojković T; Joksović L; Matić I; Todorović N; Nikolić M; Joksović MD
Bioorg Med Chem Lett; 2014 Jan; 24(1):65-71. PubMed ID: 24332490
[TBL] [Abstract][Full Text] [Related]
9. Xanthohumol, a polyphenol chalcone present in hops, activating Nrf2 enzymes to confer protection against oxidative damage in PC12 cells.
Yao J; Zhang B; Ge C; Peng S; Fang J
J Agric Food Chem; 2015 Feb; 63(5):1521-31. PubMed ID: 25587858
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of peroxynitrite-mediated LDL oxidation by prenylated flavonoids: the alpha,beta-unsaturated keto functionality of 2'-hydroxychalcones as a novel antioxidant pharmacophore.
Stevens JF; Miranda CL; Frei B; Buhler DR
Chem Res Toxicol; 2003 Oct; 16(10):1277-86. PubMed ID: 14565769
[TBL] [Abstract][Full Text] [Related]
11. AKT/NF-kappaB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies.
Dell'Eva R; Ambrosini C; Vannini N; Piaggio G; Albini A; Ferrari N
Cancer; 2007 Nov; 110(9):2007-11. PubMed ID: 17823911
[TBL] [Abstract][Full Text] [Related]
12. The In Vitro and In Vivo Antiangiogenic Effects of Flavokawain B.
Rossette MC; Moraes DC; Sacramento EK; Romano-Silva MA; Carvalho JL; Gomes DA; Caldas H; Friedman E; Bastos-Rodrigues L; De Marco L
Phytother Res; 2017 Oct; 31(10):1607-1613. PubMed ID: 28816367
[TBL] [Abstract][Full Text] [Related]
13. Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells.
Colgate EC; Miranda CL; Stevens JF; Bray TM; Ho E
Cancer Lett; 2007 Feb; 246(1-2):201-9. PubMed ID: 16563612
[TBL] [Abstract][Full Text] [Related]
14. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention.
Bhat TA; Nambiar D; Pal A; Agarwal R; Singh RP
Carcinogenesis; 2012 Feb; 33(2):385-93. PubMed ID: 22139440
[TBL] [Abstract][Full Text] [Related]
15. Xanthohumol, a prenylated chalcone derived from hops, inhibits proliferation, migration and interleukin-8 expression of hepatocellular carcinoma cells.
Dorn C; Weiss TS; Heilmann J; Hellerbrand C
Int J Oncol; 2010 Feb; 36(2):435-41. PubMed ID: 20043079
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant and antiproliferative activity of glycosides obtained by biotransformation of xanthohumol.
Tronina T; Bartmańska A; Milczarek M; Wietrzyk J; Popłoński J; Rój E; Huszcza E
Bioorg Med Chem Lett; 2013 Apr; 23(7):1957-60. PubMed ID: 23466227
[TBL] [Abstract][Full Text] [Related]
17. Xanthohumol, a prenylated chalcone derived from hops, suppresses cancer cell invasion through inhibiting the expression of CXCR4 chemokine receptor.
Wang Y; Chen Y; Wang J; Chen J; Aggarwal BB; Pang X; Liu M
Curr Mol Med; 2012 Feb; 12(2):153-62. PubMed ID: 22172099
[TBL] [Abstract][Full Text] [Related]
18. Xanthohumol inhibits cell proliferation and induces apoptosis in human thyroid cells.
Carvalho DO; Freitas J; Nogueira P; Henriques SN; Carmo AM; Castro MA; Guido LF
Food Chem Toxicol; 2018 Nov; 121():450-457. PubMed ID: 30240731
[TBL] [Abstract][Full Text] [Related]
19. Xanthohumol, a Prenylated Chalcone from Hops, Inhibits the Viability and Stemness of Doxorubicin-Resistant MCF-7/ADR Cells.
Liu M; Yin H; Qian X; Dong J; Qian Z; Miao J
Molecules; 2016 Dec; 22(1):. PubMed ID: 28036030
[TBL] [Abstract][Full Text] [Related]
20. Novel chalcone derivatives as hypoxia-inducible factor (HIF)-1 inhibitor: synthesis, anti-invasive and anti-angiogenic properties.
Wang L; Chen G; Lu X; Wang S; Han S; Li Y; Ping G; Jiang X; Li H; Yang J; Wu C
Eur J Med Chem; 2015 Jan; 89():88-97. PubMed ID: 25462229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
